EMD-62694

Single-particle
3.7 Å
EMD-62694
3D View Gallery
Deposition: 12/12/2024
Map released: 24/12/2025
Last modified: 25/02/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-62694

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9l0b summary report (pdf.gz) Map-9l0b FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

structure of MCT2-embigin complex

EMD-62694

Single-particle
3.7 Å
EMD-62694
3D View Gallery
Deposition: 12/12/2024
Map released: 24/12/2025
Last modified: 25/02/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: MCT2-embigin
Fitted models: 9l0b

Deposition Authors: Xu B , Wang Y
Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2.
Xu B , Zhou X, Shan Y , Shi S, Li J, Liang Q, Wang Z, Zhang M , Wang Y , Pei D , Ye S
(2026) EMBO Rep , 27 , 677 - 703
PUBMED: 41381736
DOI: doi:10.1038/s44319-025-00661-9
ISSN: 1469-3178